TITLE

Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol

AUTHOR(S)
Wong, Germaine; Howard, Kirsten; Chapman, Jeremy R.; Tong, Allison; Bourke, Michael J.; Hayen, Andrew; Macaskill, Petra; Hope, Richard L.; Williams, Narelle; Kieu, Anh; Allen, Richard; Chadban, Steven; Pollock, Carol; Webster, Angela; Roger, Simon D.; Craig, Jonathan C.
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p516
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Cancer is a major cause of mortality and morbidity in patients with chronic kidney disease (CKD). In patients without kidney disease, screening is a major strategy for reducing the risk of cancer and improving the health outcomes for those who developed cancers by detecting treatable cancers at an early stage. Among those with CKD, the effectiveness, the efficacy and patients' preferences for cancer screening are unknown. Methods/Design: This work describes the protocol for the DETECT study examining the effectiveness, efficiency and patient's perspectives of colorectal cancer screening using immunochemical faecal occult blood testing (iFOBT) for people with CKD. The aims of the DETECT study are 1) to determine the test performance characteristics of iFOBT screening in individuals with CKD, 2) to estimate the incremental costs and health benefits of iFOBT screening in CKD compared to no screening and 3) to elicit patients' perspective for colorectal cancer screening in the CKD population. Three different study designs will be used to explore the uncertainties surrounding colorectal cancer screening in CKD. A diagnostic test accuracy study of iFOBT screening will be conducted across all stages of CKD in patients ages 35-70. Using individually collected direct healthcare costs and outcomes from the diagnostic test accuracy study, cost-utility and cost-effective analyses will be performed to estimate the costs and health benefits of iFOBT screening in CKD. Qualitative in-depth interviews will be undertaken in a subset of participants from the diagnostic test accuracy study to investigate the perspectives, experiences, attitudes and beliefs about colorectal cancer screening among individuals with CKD. Discussion: The DETECT study will target the three major unknowns about early cancer detection in CKD. Findings from our study will provide accurate and definitive estimates of screening efficacy and efficiency for colorectal cancer, and will allow better service planning and budgeting for early cancer detection in this at-risk population. The DETECT study is also registered with the Australia New Zealand Clinical Trials Registry ACTRN12611000538943
ACCESSION #
63971489

 

Related Articles

  • Clinical image of the week.  // GP: General Practitioner;4/19/2004, p11 

    Patients need to become more aware of the symptoms of bowel cancer, according to Colon Cancer Concern survey. Results from the charity's patient survey sowed that fewer than a third of bowel cancer patients acted on their symptoms.

  • No association of the hypoxia-inducible factor-1α gene polymorphisms with survival in patients with colorectal cancer. Lee, Soo; Kim, Jong; Sohn, Sang; Chae, Yee; Moon, Joon; Kang, Byung; Park, Jun; Park, Jin; Choi, Gyu; Lee, Soo Jung; Kim, Jong Gwang; Sohn, Sang Kyun; Chae, Yee Soo; Moon, Joon Ho; Kang, Byung Woog; Park, Jun Seok; Park, Jin Young; Choi, Gyu Seog // Medical Oncology;Dec2011, Vol. 28 Issue 4, p1032 

    Hypoxia-inducible factor-1 (HIF-1) is the key regulator of cellular response to hypoxia and presumably plays a central role in the control of tumor growth. The present study analyzed polymorphisms of HIF-1α gene and their impact on the prognosis for patients with colorectal cancer. Four...

  • No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer. Kim, Yun; Lee, Soo; Kim, Jong; Sohn, Sang; Chae, Yee; Moon, Joon; Kang, Byung; Park, Jin; Park, Jun; Choi, Gyu; Kim, Yun Jeong; Lee, Soo Jung; Kim, Jong Gwang; Sohn, Sang Kyun; Chae, Yee Soo; Moon, Joon Ho; Kang, Byung Woog; Park, Jin Young; Park, Jun Seok; Choi, Gyu Seog // Medical Oncology;Dec2011, Vol. 28 Issue 4, p1075 

    Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) is involved in numerous physiologic and pathophysiologic process including tumor angiogenesis and apoptosis. Accordingly, the present study analyzed polymorphisms of eNOS gene and their impact on the prognosis for patients with...

  • Presentation and outcomes of patients aged 30 years and younger with colorectal cancer: a 20-year retrospective review. Al-Barrak, Jasem; Gill, Sharlene // Medical Oncology;Dec2011, Vol. 28 Issue 4, p1058 

    Age may influence the clinicopathological characteristics and outcome of colorectal cancer. The aim of this study is to retrospectively review the characteristics and outcomes of patients diagnosed at age 30 years and younger. All patients diagnosed with colorectal adenocarcinoma at age 30 years...

  • Chronic disease and assessing quality of life? Donnelly, Seamas C. // QJM: An International Journal of Medicine;Nov2016, Vol. 109 Issue 11, p701 

    No abstract available.

  • Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa. Nalado, Aishatu Mohammed; Mahlangu, Johnny N; Waziri, Bala; Duarte, Raquel; Paget, Graham; Olorunfemi, Gbenga; Naicker, Saraladevi // International Journal of Nephrology & Renovascular Disease;Feb2019, Vol. 12, p19 

    Introduction: Anemia is a complication of chronic kidney disease (CKD) that can greatly impact on its prognosis. However, the risk factors for anemia, including the influence of ethnicity, are not well established among the CKD population in Johannesburg. Methods: This was a cross-sectional...

  • Diagnosis of colorectal cancer from tissue sample passed per rectum. Wilson, Iain; Pancholi, Alok; Chan, Shirley // International Journal of Colorectal Disease;Aug2014, Vol. 29 Issue 8, p1021 

    A letter to the editor is presented that discusses the diagnosis of colorectal cancer from tissue sample passed per rectum.

  • Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK. Damery, Sarah; Clifford, Sue; Wilson, Sue // BMC Family Practice;2010, Vol. 11, p20 

    Background: Colorectal cancer (CRC) is the third most common cancer in the UK. Five-year survival rates are less than 50%, largely because of late diagnosis. Screening using faecal occult blood tests (FOBt) can detect bowel cancer at an earlier stage than symptomatic presentation, and has the...

  • JOHNS HOPKINS DEVELOPS COLON CANCER BLOOD TEST.  // Worldwide Biotech;Dec2005, Vol. 17 Issue 12, p7 

    Focuses on a blood test developed by researchers at the Johns Hopkins Kimmel Cancer Center and Howard Hughes Medical Institute with Indivumed for the diagnosis of colon cancer. Cancer genes detected in the blood of colorectal cancer patients; Background of Indivumed.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics